New Zealand markets open in 8 hours 32 minutes

VBI Vaccines Inc. (VBIV)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5980+0.0118 (+2.01%)
At close: 04:00PM EDT
0.5900 -0.01 (-1.34%)
Pre-market: 09:15AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 16.97M
Enterprise value 55.09M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.23
Price/book (mrq)1.24
Enterprise value/revenue 5.85
Enterprise value/EBITDA -0.69

Trading information

Stock price history

Beta (5Y monthly) 1.99
52-week change 3-70.15%
S&P500 52-week change 326.24%
52-week high 33.4700
52-week low 30.4500
50-day moving average 30.6068
200-day moving average 30.6382

Share statistics

Avg vol (3-month) 3439k
Avg vol (10-day) 3108.33k
Shares outstanding 528.68M
Implied shares outstanding 629.1M
Float 826.73M
% held by insiders 16.77%
% held by institutions 113.03%
Shares short (15 May 2024) 4302.52k
Short ratio (15 May 2024) 41.68
Short % of float (15 May 2024) 41.27%
Short % of shares outstanding (15 May 2024) 41.05%
Shares short (prior month 15 Apr 2024) 4709.47k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 328 Dec 2012
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 312 Apr 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-968.04%

Management effectiveness

Return on assets (ttm)-29.15%
Return on equity (ttm)-419.59%

Income statement

Revenue (ttm)9.41M
Revenue per share (ttm)0.48
Quarterly revenue growth (yoy)150.30%
Gross profit (ttm)N/A
EBITDA -45.58M
Net income avi to common (ttm)-83.99M
Diluted EPS (ttm)-3.5400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.6M
Total cash per share (mrq)0.44
Total debt (mrq)50.71M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.34
Book value per share (mrq)-0.22

Cash flow statement

Operating cash flow (ttm)-51M
Levered free cash flow (ttm)-29.1M